Welcome to the Hope Bio Blog

Written by Jan Shultis In 2023, Texas-based biopharmaceutical company Hope Biosciences, LLC cultured approximately 170 billion adult stem cells for use in dozens of disease and injury conditions, including in 18 FDA-authorized research protocols. It was a year that saw a new volume of peer-reviewed publications, conference presentations, and community engagements. Also in 2023, Hope Biosciences increasingly became a household name in skincare, with a partner’s very public lau

Sugar Land, Tx. (Apr 6, 2023) – As Houston-area biotechnology company Hope Biosciences marks their seventh year of service, the team remains is fixated on other numbers—numbers of mesenchymal (adult) stem cells cultured, countries served, new products launched, and FDA-authorized clinical research studies supported thus far. The answers, a testament to that very team? Four-hundred-and-four billion stem cells cultured since inception, 140 billion in this seventh year; five cou

A city built on sugar redefining itself as a frontrunner in medical innovation. A Sugar Land Space Cowboys–branded fire truck on the team’s opening day in 2022. Courtesy of the City of Sugar Land Welcome to Sugar Land, a city of world-class innovation, rich community, and expanding opportunities. It was built in the early 1800s on the production of sugar, but today the city is redefining itself as a frontrunner in medical innovation. Old Sugar Land. A piece from W.T. Eldridge